Trademark Overview
On Monday, February 24, 2025, a trademark application was filed for UNIVERSAL CANCER IMMUNOTHERAPY with the United States Patent and Trademark Office. The USPTO has given the UNIVERSAL CANCER IMMUNOTHERAPY trademark a serial number of 99053458. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Thursday, May 15, 2025. This trademark is owned by ImmunityBio, Inc.. The UNIVERSAL CANCER IMMUNOTHERAPY trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment and prevention of non-cancerous neoplasia, immunologic-related diseases, immunologic dysfunction, and cancer; Biological preparations for the treatment of non-cancerous neoplasia, immunologic-related diseases, immunologic dysfunction, and cancer; Vaccines; Veterinary pharmaceutical preparations for the prevention of non-cancerous neoplasia, immunologic-related diseases, immunologic dysfunction, and cancer; Veterinary pharmaceutical preparations for the treatment of non-cancerous neoplasia, immunologic-related diseases, immunologic dysfunction, and
cancer